Abstract
Nearly 10 years ago, coronary-artery stents were developed with the hope of preventing restenosis after coronary angioplasty, a problem that has proved all too common. The first clinical report of coronary-artery stenting, by Sigwart and colleagues, was published in the Journal in 19871. In their study, permanent metal prosthetic coronary stents were used in conjunction with a rudimentary antithrombotic medical regimen; follow-up of the first cohort of patients suggested that this approach was associated with too many thrombotic complications2.Perseverance in the past decade has led to considerable progress in coronary stenting. The Gianturco-Roubin stent, with its flexible-coil . . .